Calamos Advisors’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Calamos Advisors’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500,000	Closed	-$28K	–	1027
2023 Q3	$28K	Hold	500,000	–	–	﹤0.01%	805
2023 Q2	$68.3K	Hold	500,000	–	–	﹤0.01%	809
2023 Q1	$42.9K	Hold	500,000	–	–	﹤0.01%	940
2022 Q4	$23K	Buy	+500,000	New	+$25.6K	﹤0.01%	1031

Calamos Advisors's BIOSW Position: Q4 2023 in Review

Calamos Advisors sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 500,000 shares — an estimated $28K sold.

Calamos Advisors first reported a position in BIOSW in Q4 2022 and held it in 4 quarters. The position peaked at $68.3K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Calamos Advisors reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Calamos Advisors sold 500,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $28K.
Calamos Advisors first reported a position in BioPlus Acquisition Corp. Warrants in Q4 2022 and held it in 4 quarters.
Calamos Advisors's BioPlus Acquisition Corp. Warrants position peaked at $68.3K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.